http://www.unboundmedicine.com/medline/ebm/research/histrelinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19920916/full_citation/Experience_with_the_once_yearly_histrelin__GnRHa__subcutaneous_implant_in_the_treatment_of_central_precocious_puberty_Lewis KA, Eugster EA 
Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty. [JOURNAL ARTICLE]
Drug Des Devel Ther 2009.:1-5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19874874/full_citation/Hypothalamic_gonadotropin_releasing_hormone_receptor_activation_stimulates_oxytocin_release_from_the_rat_hypothalamo_neurohypophysial_system_while_melatonin_inhibits_this_process_Juszczak M, Boczek-Leszczyk E 
Hypothalamic gonadotropin-releasing hormone receptor activation stimulates oxytocin release from the rat hypothalamo-neurohypophysial system while melatonin inhibits this process. [JOURNAL ARTICLE]
Brain Res Bull 2009 Oct 26.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19820037/full_citation/Relationships_between_FSH_inhibin_B_anti_Mullerian_hormone_and_testosterone_during_long_term_treatment_with_the_GnRH_agonist_Histrelin_in_patients_with_prostate_cancer_Eldar-Geva T, Libery G, Chertin B, et al. 
Relationships between FSH, inhibin B, anti-Mullerian hormone and testosterone during long-term treatment with the GnRH-agonist Histrelin in patients with prostate cancer. [JOURNAL ARTICLE]
Eur J Endocrinol 2009 Oct 9.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19228148/full_citation/A_review_of_the_use_of_histrelin_acetate_in_the_treatment_of_prostate_cancer_Crawford ED 
A review of the use of histrelin acetate in the treatment of prostate cancer. [Journal Article, Research Support, Non-U.S. Gov't]
BJU Int 2009 Mar.:14-22.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19228147/full_citation/A_review_of_the_pharmacokinetic_and_pharmacological_properties_of_a_once_yearly_administered_histrelin_acetate_implant_in_the_treatment_of_prostate_cancer_Schlegel P 
A review of the pharmacokinetic and pharmacological properties of a once-yearly administered histrelin acetate implant in the treatment of prostate cancer. [Journal Article, Research Support, Non-U.S. Gov't]
BJU Int 2009 Mar.:7-13.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19104235/full_citation/Treatment_of_central_precocious_puberty_Kaplowitz PB 
Treatment of central precocious puberty. [Journal Article]
Curr Opin Endocrinol Diabetes Obes 2009 Feb; 16(1):31-6.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19025432/full_citation/Increased_risk_of_metabolic_syndrome_diabetes_mellitus_and_cardiovascular_disease_in_men_receiving_androgen_deprivation_therapy_for_prostate_cancer_Kintzel PE, Chase SL, Schultz LM, et al. 
Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer. [Journal Article]
Pharmacotherapy 2008 Dec; 28(12):1511-22.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18574491/full_citation/Partial_androgen_suppression_consequent_to_increased_secretion_of_adrenal_androgens_in_a_patient_with_prostate_cancer_treated_with_long_acting_GnRH_agonists_Spitz IM, Chertin B, Fridmans A, et al. 
Partial androgen suppression consequent to increased secretion of adrenal androgens in a patient with prostate cancer treated with long-acting GnRH agonists. [JOURNAL ARTICLE]
Prostate Cancer Prostatic Dis 2008 Jun 24.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/17327379/full_citation/Efficacy_and_Safety_of_Histrelin_Subdermal_Implant_in_Children_with_Central_Precocious_Puberty:_A_Multicenter_Trial_Eugster EA, Clarke W, Kletter GB, et al. 
Efficacy and Safety of Histrelin Subdermal Implant in Children with Central Precocious Puberty: A Multicenter Trial. [JOURNAL ARTICLE]
J Clin Endocrinol Metab 2007 Feb 27.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/16985882/full_citation/Comparison_of_single_agent_androgen_suppression_for_advanced_prostate_cancer_Lepor H 
Comparison of single-agent androgen suppression for advanced prostate cancer. [Journal Article]
Rev Urol 2005.:S3-S12.
Abstract | Full Citation | Find Related Articles